Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank69
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P69
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202426.19%
2023-972.92%
202279.73%
2021-38.19%
202028.01%
2019-64.36%
2018-28.51%
2017-777.54%
2016107.59%
2015-17.82%